Seventh stakeholders' forum on the implementation of the new pharmacovigilance legislation

  • Email
  • Help

Details

TitleSeventh stakeholders' forum on the implementation of the new pharmacovigilance legislation
Date27/09/2013 - 27/09/2013
LocationEuropean Medicines Agency, London, UK
SummaryThis stakeholders' forum is intended to provide an update on key changes and aspects implemented since the sixth stakeholders' forum and to share positive and negative experiences on the implementation of the pharmacovigilance legislation across all stakeholders. Registration closed.

All documents

Name Language First published Last updated
Agenda - Seventh stakeholders' forum on the implementation of the new pharmacovigilance legislation (English only) 2013-10-07  
Presentation - Pharmacovigilance – risk-benefit monitoring cycle. A global undertaking (Fergus Sweeney) (English only) 2013-10-07  
Presentation - PRAC’s perspective on implementation: strengthening public-health protection (June Raine) (English only) 2013-10-07  
Presentation - Implementing the pharmacovigilance legislation: focus on European Union level activities (Peter Arlett) (English only) 2013-10-07  
Presentation - Croatia’s perspective on implementation of the new pharmacovigilance legislation (Marina Dimov Di Giusti) (English only) 2013-10-07  
Presentation - The new pharmacovigilance legislation. A national agency’s views (Sabine Straus) (English only) 2013-10-07  
Presentation - July 2012 – September 2013: do patients see an impact of the new pharmacovigilance measures? (François Houÿez) (English only) 2013-10-07  
Presentation - European Patients Forum member survey on pharmacovigilance. First results and tentative conclusions (Kaisa Immonen-Charalambous) (English only) 2013-10-07  
Presentation - Pharmacovigilance legislation present situation and perspectives for Polish patients (Rafal Swierzewski) (English only) 2013-10-07  
Presentation - Making medicines affordable (Ana Maria Tomé) (English only) 2013-10-07  
Presentation - Industry perspective: Non-prescription medicines (Hubertus Cranz) (English only) 2013-10-07  
Presentation - New European Union pharmacovigilance legislation. Innovative industry’s perspective on implementation. First year experience (Laurent Auclert) (English only) 2013-10-07  
Presentation - Geriatrician’s perspective on implementation of the new pharmacovigilance legislation (Jean-Pierre Baeyens) (English only) 2013-10-07  
Presentation - Implementation of the pharmacovigilance legislation. The views of physicians (Erzsébet Podmaniczky) (English only) 2013-10-07  
Presentation - Implementation of the pharmacovigilance directive (John Chave) (English only) 2013-10-07  

Media Videos

Welcome and introduction


 

Implementing the pharmacovigilance legislation: what has been achieved?


 

PRAC's perspective on implementation


 

Member States' perspective on implementation


 

Member States' perspective on implementation


 

Patients' perspective on implementation


 

Patients' perspective on implementation


 

Patients' perspective on implementation


Industry's perspective on implementation


Industry's perspective on implementation


 

Industry's perspective on implementation


Healthcare professionals' perspective on implementation


Healthcare professionals' perspective on implementation


 

Healthcare professionals' perspective on implementation


 

Questions and Answers and conclusion